Yatsen Filed 2024 Annual Report on Form 20-F

Yatsen Filed 2024 Annual Report on Form 20-F

GUANGZHOU, China, April 22, 2025 /PRNewswire/ -- Yatsen Holding Limited ("Yatsen" or the "Company") (NYSE: YSG), a leading China-based beauty group, today announced that the Company has filed its annual report on Form 20-F for the fiscal year ended...

Venus Medtech Reports 2024 Annual Results: Profitability Surges with Robust Global Expansion and Innovations

Venus Medtech Reports 2024 Annual Results: Profitability Surges with Robust Global Expansion and Innovations

HONG KONG, April 22, 2025 /PRNewswire/ -- Venus MedTech (Hangzhou) Inc. (Stock Code: 2500.HK, hereinafter referred to as "Venus Medtech" or the "Company"), a global leader in structural heart therapies, has announced financial results for the year...

Euclid Transactional Adds First Tax Underwriter Based in APAC

Euclid Transactional Adds First Tax Underwriter Based in APAC

SINGAPORE, April 22, 2025 /PRNewswire/ -- Euclid Transactional, LLC ("Euclid Transactional"), a leading managing general agent focused on transactional insurance underwriting and claims handling, today announced that Wai Ling Low has joined as...

FIELD MEDICAL CLOSES $40 MILLION SERIES A FINANCING TO REDEFINE PULSED FIELD ABLATION FOR VENTRICULAR TACHYCARDIA

FIELD MEDICAL CLOSES $40 MILLION SERIES A FINANCING TO REDEFINE PULSED FIELD ABLATION FOR VENTRICULAR TACHYCARDIA

CARDIFF-BY-THE-SEA, Calif., April 22, 2025 /PRNewswire/ -- Field Medical Inc., a pioneer in cardiac pulsed field ablation (PFA) technology, today announced the successful closing of $40 million in Series A financing. The round includes $20 million...

BGM Group Acquires Wonder Dragon to Accelerate "Healthcare" Strategy

BGM Group Acquires Wonder Dragon to Accelerate "Healthcare" Strategy

CHENGDU, China, April 21, 2025 /PRNewswire/ -- BGM Group Ltd. (Nasdaq: BGM) today announced that it has signed a definitive transaction agreement with the existing shareholders of Wonder Dragon Global Limited ("Wonder Dragon"), to acquire 100% of...

Acepodia Presents Preclinical Data on Antibody-Dual-Drugs Conjugation (AD2C) technology at AACR Annual Meeting 2025

Acepodia Presents Preclinical Data on Antibody-Dual-Drugs Conjugation (AD2C) technology at AACR Annual Meeting 2025

ALAMEDA, Calif. and TAIPEI, April 21, 2025 /PRNewswire/ -- Acepodia (6976: TT) today announced the presentation of new preclinical data highlighting its proprietary dual-payload antibody-drug conjugate (AD2C) for hepatocellular carcinoma (HCC). The...

Yunji Announces Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results

Yunji Announces Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results

HANGZHOU, China, April 21, 2025 /PRNewswire/ -- Yunji Inc. ("Yunji" or the "Company") (NASDAQ: YJ), a leading membership-based social e-commerce platform, today announced its unaudited financial results for the fourth quarter and fiscal year ended...

FinVolution Group Files 2024 Annual Report on Form 20-F

FinVolution Group Files 2024 Annual Report on Form 20-F

SHANGHAI, April 19, 2025 /PRNewswire/ -- FinVolution Group ("FinVolution," or the "Company") (NYSE: FINV), a leading fintech platform in China, Indonesia and the Philippines, today announced that it has filed its annual report on Form 20-F for the...

iQIYI leads agile, IP-and tech-powered offline experience with plan for second theme park in China

iQIYI leads agile, IP-and tech-powered offline experience with plan for second theme park in China

BEIJING, April 18, 2025 /PRNewswire/ -- On Apr. 18, iQIYI, China's leading online entertainment platform, announced the groundbreaking of its second comprehensive theme park, iQIYI LAND, in Kaifeng, Henan Province, Central China. This milestone...

WuXi Biologics Completes First Commercial PPQ Campaign at 15,000L Production Line in Hangzhou Site

WuXi Biologics Completes First Commercial PPQ Campaign at 15,000L Production Line in Hangzhou Site

- The campaign marks the successful commercial-scale PPQ completion of Asia's first 3 X 5,000L single-use bioreactors - Proprietary process innovation reduces protein cost by nearly 70% while boosting yield 20% - As the company's largest operational...

  • 1
  • ...
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • ...
  • 96
  • menu
    menu